FluBlok: Clinical Trials

6 trials of FluBlok, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 6
Phase 21Completed 1

Follow FluBlok: new trials by email Literature Review of FluBlok trials Research Report on FluBlok

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age
31-valent pneumococcal conjugate vaccine, Seasonal Influenza Vaccine (SIV) (Flublok), Placebo - Pneumococcal Disease
Phase 3CompletedVaxcyte, Inc.13902026-01-122026-11-13
Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age
Flublok, Afluria - Influenza
Phase 3CompletedProtein Sciences Corporation26402013-03-012015-02-18
Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok
FluBlok®, Placebo - Influenza
Phase 3CompletedSanofi46482007-09-152022-04-06
Safety and Reactogenicity of FluBlok and Comparison of Immunogenicity, Efficacy and Effectiveness Against TIV
FluBlok Influenza Vaccination, TIV (Fluzone) Influenza Vaccination - Influenza
Phase 3CompletedProtein Sciences Corporation6022007-09-012011-07-27
Comparison of the Immunogenicity, Safety and Reactogenicity of FluBlok, To a Licensed Vaccine In Elderly Adults
Influenza Vaccination - Influenza
Phase 3CompletedProtein Sciences Corporation8702006-10-012009-12-17
Immunogenicity and Safety of Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Adults
Influenza Vaccine, recombinant Hemagglutinin - Influenza
Phase 2 / Phase 3CompletedProtein Sciences Corporation4592004-11-012010-01-12

Conditions studied

Influenza, Human (5)  ·  Pneumococcal Infections (1)  ·  Pneumonia (1)

Sponsors

Protein Sciences Corporation (4)  ·  Sanofi (1)  ·  Vaxcyte, Inc. (1)

Countries

United States (6)

Top investigators

Alan C. Wine, MD (1)  ·  Bob Weiss, MD (1)  ·  Brandon Essink, MD (1)  ·  Darrell Herrington, DO (1)  ·  Eric Sheldon (1)  ·  Frank Eder, MD (1)  ·  George Bauer, MD (1)  ·  Gregory A. Poland, MD (1)  ·  Hana M. El-Sahly, MD (1)  ·  Jeffrey Rosen, MD (1)  ·  Joe Blumenau, MD (1)  ·  John J Treanor, MD (1)  ·  John J. Minneti, MD (1)  ·  John J. Treanor, MD (1)  ·  John Treanor, MD (1)

Results publications

PMID 26787832, PMID 28325769, PMID 17426277, PMID 19879222, PMID 21277410, PMID 26529070